Blaze Bioscience
Facts
- Sectors
- Biotech, Medical
- Founded
- 2011 Seattle business license
- Type
- Corporation Seattle business license
- Registered name
- Blaze Bioscience Inc Seattle business license
- Total raised
- $98M SEC Form D filings Total of this company's SEC Form D filings
- Last round
- $8.1M · Feb 2024 SEC Form D
- Founders
- James Olson
GeekWire Awards 2020 Goes Virtual; Ally Wins Startup of the Year as Bill Gates and Celebrities Celebrate
GeekWire held a virtual GeekWire Awards livestream honoring top Pacific Northwest tech companies and leaders across 12 categories, with winners accepting via Zoom and special video messages from figures like Bill Gates. Seattle startup Ally won Startup of the Year, and the event included entertainment such as The Drunken Tenorperforming an "Opera di Zoom."
Athira Pharma raises $85M Series B to push NDX-1017 toward FDA approval for Alzheimer’s, Parkinson’s and ALS
Seattle biotech Athira Pharma raised $85 million in a Series B round to advance NDX-1017, a regenerative therapy aimed at halting or reversing nerve damage in Alzheimer’s, Parkinson’s and ALS, with preliminary trial results reported as positive and potential market availability in 2–3 years.
U.S. VC Funding Falls 46% in April to $7.3B; Washington State Raises $190M in 21 Deals Led by Health and Biotech
U.S. venture capital investment plunged in April — down 46% from March to $7.3 billion and 43% year-over-year — while Washington state fared better with $190 million across 21 deals, helped by health and life-sciences financings.
